Pain is a distressing sensory & emotional sensation similar to existing or potential tissue injury. It is an uncomfortable sensation, like a tingle, sting, prick burn, or soreness. Pain might be subtle or intense and It could be continual or intermittent. The patient may experience discomfort in their entire body or just one place, such as their back, abdomen, chest, and pelvis. Pain can also aid in the diagnosis of a problem. Acute pain and chronic pain are two different types of pain. Acute pain frequently appears out of nowhere because of a condition, an injury, or inflammation. It is frequently treatable and diagnosable. Usually, it fades away, but occasionally, it can develop into persistent pain.
On the other hand, chronic pain lasts for a long time and can cause severe problems. The main causes of chronic pain include nerve damage and injury, bone and joint ageing, and other disorders. A specific class of medications is used to treat or manage pain and its effects in long term. The pain process is intricate, but there are several medications that can help by acting through different physiological mechanisms. The most common type of painkiller prescribed is an opioid. These are narcotic painkillers that contains both natural and synthetic opiates. Opioids are typically used to treat acute pain, such as the immediate postoperative discomfort. Additionally, other opioids used for the tretamnet of pain includes morphine, fentanyl, oxycodone, and codeine. Treatment of pain is based on the nature and source of pain. Pain management also includes therapies and devices that help alleviate the pain. Additionally, there are non-drug therapies like acupuncture, physical therapy, and occasionally surgery.
The "Global pain management therapeutics market analysis to 2030" is a specialized and in-depth study of the pharmaceutical industry with a special focus on global market trend analysis. The report aims to provide an overview of the pain management therapeutics market with detailed market segmentation by drug class, indication, distribution channel, and geography. The report provides key statistics on the market status of the leading pain management therapeutics market players and offers key trends and opportunities in the market.
The pain management therapeutics market size is segmented into drug class, indication, distribution channel, and region. Based on drug class, the global pain management therapeutics market is differentiated into NSAIDS, anesthetics, anticonvulsant, anti-migraine drugs, antidepressant drugs, opioids and others. By indication, the pain management therapeutics market is classified into arthritic pain, neuropathic pain, cancer pain, chronic pain, post-operative pain, migraine, fibromyalgia, bone fracture and others. By distribution channel, the pain management therapeutics market is segmented into hospital pharmacies, retail pharmacies and online pharmacies.
The market for pain management therapeutics is favorably impacted by the increasing demand for pain relief medications, rising healthcare costs, increerasing disease knowledge among physicians and patients, and numerous R&D projects. According to the National Health Statistics, over 310 million major procedures are carried out annually, of which 40 to 50 million take place in the US and 20 million in Europe. Additionally, the number of surgeries performed globally is increasing, which is the main factor driving the use of painkillers. The pain management therapeutics market is consequently driven by increased cancer therapies linked to pain incidence and a growing elderly population using different therapies. In addition, increased traffic and road accidents cause relative trauma injuries that increase the need for postoperative pain management. Additionally, as per WHO estimates evaey years ~1.3 million people dies in traffic accidents. Around 20 and 50 million people worldwide experience non-fatal injuries, and many of them develop disabilities as a result of their injuries. The great availability, ease of access, increased knowledge, cost-effectiveness, and speed of alleviating pain management medicines affect consumer preference. However, the pain management therapeutics market expansion is constrained by the escalating worries about drug exploitation. Furthermore, the market for pain management therapeutics market is anticipated to benefit greatly from recent developments in pain management based on nanoparticles.
Due to the availability of improved pain care treatment, the rising number of patients with chronic diseases, the availability of advantageous insurance policies, and the expanding base of the ageing population, the North American pain management therapeutics market is anticipated to account for a considerable revenue share. The market is expected to expand more quickly as the elderly population grows since they are more likely to develop chronic illnesses. Additionally, it is anticipated that growing partnerships and agreements between regional and worldwide firms will assist the target market's revenue growth. The presence of several players operating in the nation and a strategy for introducing novel solutions are projected to spur the expansion of the target market.
The Asia-Pacific pain management therapeutics market is anticipated to grow at the significant rate during the forecast period. One of the main factors propelling the growth of the pain management therapeutics market is the rising prevalence of diseases including cancer, diabetic neuropathy, osteoarthritis, and chronic arthritis. Other important drivers include the rising number of surgical procedures and rising healthcare spending. However, the expansion of the market for pain management therapeutics has been significantly constrained by reasons such the rise in generic completeness, the patent expiration of blockbuster drugs, and the accessibility of alternatives like pain relief devices. Additionally, prescribing drug abuse will restrain the market's expansion.
The report covers key pain management therapeutics market developments, such as organic and inorganic growth strategies. Various companies such as Abbott, AstraZeneca, BoehringerIngelheim, Eli Lilly & Company, Mylan N.V., Pfizer, Depomed Inc., Endo International Plc., GlaxoSmithKline Plc., Johnson & Johnson, Merck & Co. Inc., Novartis AG, Purdue Pharma L.P., Teva Pharmaceutical Industries and others are focusing on organic growth strategies such as product launches, product approvals, and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, partnerships & collaborations. These activities have paved the way for the expansion of business and the customer base of market players. The market players from the pain management therapeutics market are anticipated to have lucrative growth opportunities with the rising demand for pain management therapeutics in the global market.
Key Developments in Global Pain Management Therapeutics Market
- In October 2022, Parker Laboratories, Inc launched two powerfully effective topical pain management creams Helix Tri-Active and Helix with CBD, which offer new options for patients battling chronic pain.
- In August 2022, Myovant Sciences and Pfizer Received U.S. FDA approval for MYFEMBREE, a once-daily treatment for managing moderate to severe pain associated with endometriosis.
- In October 2021, Esteve Pharmaceuticals received U.S. Food and Drug Administration (FDA) approval for SEGLENTIS, which is used to treat individuals with acute pain that is severe enough to need an opioid analgesic but not sufficiently managed by other methods.
- In 2020, Senza Omnia Spinal Cord Stimulation System was introduced by NeuroPace, Inc. in the US to treat chronic pain. This is anticipated to assist the business in expanding its product line and improving its profit margin.
The report also includes key companies' profiles, their SWOT analysis, and market strategies in the pain management therapeutics market growth. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information for the last three years, and key development in the past five years.
The Insight Partner’s dedicated research and analysis team comprises experienced professionals with advanced statistical expertise and offers various customization options in the current study.
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
This text is related
to segments covered.
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
This text is related
to country scope.
The List of Companies
1. NOVARTIS AG
2. ELI LILLY AND COMPANY
3. ABBOTT LABORATORIES
4. ENDO HEALTH SOLUTIONS, INC
5. PURDUE PHARMA L.P.
6. PFIZER, INC.
7. MYLAN NV.
8. MERCK AND CO. INC
9. JOHNSON AND JOHNSON
10. GLAXOSMITHKLINE PLC.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Drug Delivery Market
Forecast to 2028 - Global Analysis By Route of Administration (Injectable Drug Delivery, Oral Drug Delivery, Transmucosal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, and Ocular Drug Delivery), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and End User (Hospitals and Clinics, Home Care Settings, and Other End User)
Enteral and Parenteral Medical Nutrition Market
Forecast to 2028 - Global Analysis by Indication [Elderly, Gastrointestinal Disorders (IBD, IBS, and Others), Diabetes, Cancer, Respiratory Disorders, Alzheimer's Disease, Dementia, Renal Disease, Liver Failure, Post COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole–Source), Form (Liquid, Powder, and Semi–Solid), Product Type (General and Disease–Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, 18–60 Years, 3–18 Years, and Below 3 Years), and Distribution Channel (Hospital Pharmacies, Retail Stores, E-Commerce, and Others)
CIN & HR-HPV Treatment Market
Forecast to 2028 - Global Analysis By Disease Type (Cervical Intraepithelial Neoplasia 1, Cervical Intraepithelial Neoplasia 2, and Cervical Intraepithelial Neoplasia 3), Strain Type (HPV 16, HPV 18, and Others), Offering (Diagnostic Method and Treatment), Product Type (Kits & Reagents, Instruments, and Services), and End User (Hospitals & Clinics, Diagnostic Laboratories, Specialized Clinical Laboratories, and Others)
Pharmaceutical Fluid Handling Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Offering (Equipment & Solutions and Services), Tubing (Thermoplastic Elastomers, Polyvinyl Chloride, and Silicone), Application (Fluid Handling & Management, Fluid Preparation, Integration & Automation, Buffer Management, and Others), Usage (Cough Syrup, Intravenous Product, Complex Active Pharmaceutical Ingredients, and Others), and End User (Biotechnology Companies, Pharmaceutical & Medical Companies, and Others)
Enteral Medical Nutrition Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Indication (Respiratory Disorders, Cancer, Post COVID-19, Gastrointestinal Disorders, Liver Failure, and Others), Nutrition Type (Supplemental and Sole-Source), Form (Powder, Liquid, and Semi-Solid), Product (Standard Protein Diet, High Protein Diet, Fruit Juice Based Oral Nutritional Supplement, and Others), Distribution Channel (Hospital Pharmacies, Retail Stores, and Others), and Age Group [Child (Till 18 Years) and Adults (18+years)]
Glycomic Therapeutics Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Class (Isolated and Synthetic), Structures [Glycoproteins, Targeting Sialic Acid, Proteoglycans, Targeting Glycosaminoglycans, Glycosylphosphatidylinositol (GPI)-Anchored Proteins & Heparin Based Glycans, Targeting Glycosphingolipids, and Others], Indications (Thrombosis & Chemoprophylaxis, Anaemia, Anti-Adhesive & Anti-Inflammatory, Cataracts, Gaucher’s Disease, MPS-1 & IV, Cancer, Alzheimer’s Disease, Influenza Type A & B, and Others), and Mode of Action [Inhibits Neuraminidase; Inhibits Heparanase and Selectins and Blocks Interactions Between Growth Factors and Heparan Sulfate; Erythropoietin & Enzyme Replacement Therapy (ERT); Tissue Plasminogen Activator; Inhibits Glucosylceramide Synthase; Interleukin 1, 2 & 3; Beta & Gamma Interferons; and Others]